CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335 | -8.5% | 28,682 | +5.3% | 0.00% | 0.0% |
| Q2 2023 | $366 | -27.5% | 27,226 | -10.6% | 0.00% | -33.3% |
| Q1 2023 | $505 | -8.5% | 30,457 | +2.6% | 0.00% | -25.0% |
| Q4 2022 | $552 | -99.9% | 29,678 | -7.2% | 0.00% | +33.3% |
| Q3 2022 | $410,000 | +272.7% | 31,993 | +104.0% | 0.00% | +200.0% |
| Q2 2022 | $110,000 | -34.1% | 15,685 | -22.3% | 0.00% | 0.0% |
| Q1 2022 | $167,000 | +32.5% | 20,193 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $126,000 | +50.0% | 18,642 | +17.4% | 0.00% | – |
| Q3 2021 | $84,000 | +12.0% | 15,885 | +22.0% | 0.00% | – |
| Q2 2021 | $75,000 | +47.1% | 13,022 | +17.4% | 0.00% | – |
| Q1 2021 | $51,000 | – | 11,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |